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SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and
proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some
human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2
in gastric epithelial cell lines. Exogenous expression of SOX2 suppressed cell proliferation in gastric epithelial cell lines. Flow cytometry
analysis revealed that SOX2-overexpressing cells exhibited cell-cycle arrest and apoptosis. We found that SOX2-mediated cell-cycle
arrest was associated with decreased levels of cyclin D1 and phosphorylated Rb, and an increased p27
Kip1 level. These cells exhibited
further characteristics of apoptosis, such as DNA laddering and caspase-3 activation. SOX2 hypermethylation signals were observed in
some cultured and primary gastric cancers with no or weak SOX2 expression. Among the 52 patients with advanced gastric cancers,
those with cancers showing SOX2 methylation had a significantly shorter survival time than those without this methylation
(P¼0.0062). Hence, SOX2 plays important roles in growth inhibition through cell-cycle arrest and apoptosis in gastric epithelial cells,
and the loss of SOX2 expression may be related to gastric carcinogenesis and poor prognosis.
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Gastric cancer is the second most frequent cause of death from
cancer in both sexes in the world (Shibuya et al, 2002). Although
several environmental factors, such as Helicobacter pylori infec-
tion, excessive intake of salt and low intake of vegetables and fruit,
have been linked with gastric carcinogenesis, the molecular
mechanisms underlying gastric carcinogenesis are poorly under-
stood yet (Peek and Blaser, 2002; Yuasa, 2003). In recent years, the
relation between anomalous expression of transcription factors,
such as SOX, CDX and GATA, and carcinogenesis has been focused
on in various cancers, including gastric cancer (Akiyama et al,
2003; Yuasa, 2003).
The SOX gene family has been identified through their
homology to the high-mobility group (HMG) box of
sex-determining region Y, and encodes transcription factors that
bind to DNA through a HMG domain and play critical roles in cell
fate determination, differentiation and proliferation (Wegner,
1999; Kamachi et al, 2000; Wilson and Koopman, 2002). SOX2
belongs to group B of the SOX family, and is encoded by a single
exon gene that is highly conserved in vertebrates. In fact, human
SOX2 shares a 98% overall similarity with the mouse protein, and
95% with the chicken homologue cSox2 (Pevny and Lovell-Badge,
1997). Sox2 mRNA has been detected in the brain, retina, lung and
stomach in adult mouse tissues (Yuan et al, 1995). In chicken,
cSox2 protein is expressed in epithelial cells of the proventriculus
and gizzard (Ishii et al, 1998). The caudal limit of cSox2 expression
coincides with that of the region competent for proventricular
differentiation and to the rostral limit of expression of CdxA, a
chicken member of the caudal-related homeobox gene family (Ishii
et al, 1998). In the human digestive tract, SOX2 expression is found
in the stomach, including fundic and pyloric mucosae, but not in
the intestine, as observed in chicken (Tsukamoto et al, 2004).
Furthermore, our previous study demonstrated that SOX2 protein
levels were reduced in gastric carcinoma tissues compared with
normal gastric epithelia (Li et al, 2004). Although decreased
expression of SOX2 might be related with carcinogenesis of the
human gastric epithelium, the roles of SOX2 in gastric carcinogen-
esis remain unclear.
Epigenetic gene silencing through DNA methylation is one of
the important steps during carcinogenesis, including that in the
stomach (Esteller et al, 2001; Jones and Baylin, 2002). To date, it
has been reported that a large number of tumour-related genes
were epigenetically silenced in human gastric cancers (Akiyama
et al, 2003; Wen et al, 2006). Recently, it was reported that SOX18,
a member of the SOX family, was methylated in lung carcinoma
(Dammann et al, 2005). Other SOX factors, such as SOX4 and
SOX9, have been reported as tumour-suppressive proteins in
bladder (Aaboe et al, 2006), breast (Afonja et al, 2002), prostate
(Drivdahl et al, 2004) and colon carcinomas (Jay et al, 2005).
However, it is not clear whether or not SOX2 has tumour-
suppressive function in gastric cells. Here, to determine how SOX2
is involved in gastric carcinogenesis, we carried out functional
characterisation of SOX2 in human and rat gastric epithelial cell
lines. We further investigated the SOX2 methylation status in
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shuman cultured and primary gastric cancer cells to clarify the
mechanisms underlying the loss of SOX2 expression in gastric
cancers.
MATERIALS AND METHODS
Cell lines and tissue samples
Ten human gastric cancer cell lines (MKN7, MKN45, MKN74,
NUGC3, NUGC4, GCIY, TGBC11TKB, KATOIII, HSC58 and
HSC59) were obtained as described previously (Tani et al, 2007).
Rat gastric epithelial cell line OUMS37 was obtained from Dr
Masayoshi Namba (Okayama University Medical School, Japan)
(Pu et al, 1999). All the cell lines were cultured in appropriate
medium. For demethylation studies, cells were daily treated with
5mM 5-aza-20-deoxycytidine (Sigma, St Louis, MO, USA) for 48h
(Wen et al, 2006). A total of 74 primary gastric carcinoma tissue
samples and corresponding noncancerous gastric mucosae were
obtained as described previously (Wen et al, 2006). Informed
consent was obtained from all subjects, and the study was
approved by the institutional review committee. Genomic DNA
was extracted using the standard phenol–chloroform procedure.
Total RNA was extracted by using Trizol reagent (Invitrogen,
Carlsbad, CA, USA) and treated with DNA-freet (Ambion Inc.,
Austin, TX, USA).
RT–PCR
For single-stranded cDNA synthesis, 1mg (for cell lines) or 2mg
(for tissue samples) of total RNA was reverse transcribed using a
Superscript II kit (Invitrogen). The amplification was performed
by denaturation at 941C for 4min, followed by 21–38 cycles of
1min each at 941C, 55–641C and 721C, and a final extension at
721C for 5min. Primer sequences used for all genes are available
upon request.
Quantitative real-time RT–PCR
Quantitative real-time RT–PCR was carried out using LightCycler
FastStart DNA Master SYBR Green I (Roche Diagnostic,
Mannheim, Germany) and LyghtCycler software version 3.5
(Roche Diagnostic), according to the manufacturer’s instructions.
As an internal control, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was quantified using LightCycler Primer Set (Search LC
GmbH, Heidelberg, Germany). Primer sequences used for SOX2
are available upon request. The Second Derivative Maximum
method was performed for the determination of concentration
using LightCycler software version 3.5 (Roche Diagnostic).
Adenovirus vector generation and infection
To generate the Ad-SOX2 vector, the human SOX2 gene was
subcloned into the pAdTrack-CMV shuttle vector (He et al, 1998)
from the pME18S-SOX2 vector (Li et al, 2004). The Ad-GFP vector
without any insert was generated as a control vector. The virus
titre was determined by using Adeno-Xt Rapid Titer Kit
(TAKARA BIO INC., Shiga, Japan), and infection was performed
with the optimum MOI (ifu/cell) for each cell line to give at least
70% green fluorescent protein (GFP)-positive cells with minimal to
no cytotoxicity.
Small interfering RNA transfection
MKN45 and TGBC11TKB cells (5 10
5 cells/well) were transfected
with SOX2 small interfering RNA (siRNA) (Sigma) to give a final
concentration of 50nM by using MicroPorator MP-100 (Digital Bio
Technology, Seoul, Korea), according to the manufacturer’s
instructions. At 48h after transfection, cells were harvested for
western blot analysis. The nonspecific siRNA was used as a control
(Neg control siRNA/Alexa Fluor 488, QIAGEN, Valencia, CA,
USA).
Western blot
Western blot analyses were performed as described previously (Li
et al, 2004). The primary antibodies used were rabbit anti-SOX2
(1:1000; Chemicon International, Temecula, CA, USA; Li et al,
2004), mouse anti-cyclin D1 (1:200; Novocastra Laboratories Ltd,
Newcastle, UK), rabbit anti-phospho (Ser780)-Rb (1:1000; Cell
Signaling Technology, Danvers, MA, USA), mouse anti-p27
Kip1
(1:2500; BD Transduction Laboratories, Franklin Lakes, NJ, USA),
mouse anti-PARP (1:2000; Sigma), mouse anti-caspase-3 (1:1000;
Cell Signaling Technology), rabbit anti-cleaved caspase-3 (1:1000;
Cell Signaling Technology), mouse anti-p21
Cip1 (1:100; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and mouse anti-a-tubulin
(1:200; Santa Cruz Biotechnology). The secondary antibodies used
were alkaline phosphatase-conjugated anti-mouse IgG or anti-
rabbit IgG (1:2000; Bio-Rad Laboratories, Hercules, CA, USA).
Blots were developed with Immun-Start AP Substrate (Bio-Rad).
Cell proliferation assay
OUMS37 cells were plated at 5 10
2 cells/well, and NUGC3 and
GCIY cells at 1 10
3 cells/well on 96-well plates. After culturing
for 24h, cells were infected with Ad-SOX2 or control Ad-GFP at
the optimal MOI. Cell proliferation was evaluated on days 1, 3 and
5 after infection by determining the number of cells with Cell
Proliferation Reagent WST-1 (Roche Diagnostic), according to the
manufacturer’s instructions.
Flow cytometry
At 24, 48 and 72h after infection, OUMS37 cells were harvested
and washed with PBS, followed by fixation with 70% ethanol
overnight at  201C. After washing with 3% BSA/PBS twice, the
cells were resuspended in PBS containing 50mgml
 1 propidium
iodide and 10mgml
 1 RNase A for 30min at room temperature in
the dark. Samples were analysed for DNA content by flow
cytometry. The cell-cycle phases were analysed using CELLQuest
software (Becton Dickinson, San Jose, CA, USA).
APOPercentage Apoptosis assay
OUMS37 cells were plated at 2.5 10
3 cells/well on 96-well plates.
After culturing for 24h, the cells were infected with Ad-SOX2 or
control Ad-GFP at the optimal MOI. The culture medium was
replaced with fresh medium containing APOPercentage Dye
(Biocolor, Belfast, Northern Ireland) at 24, 48 and 72h after
infection, followed by incubation for 1h at 371C/5% CO2. After
replacing the culture medium containing APOPercentage Dye with
PBS, apoptotic cells exhibiting purple-red staining were counted
under a phase contrast microscope in 10 random fields, and their
percentage in total cells was calculated.
DNA ladder assay
At 48 and 72h after infection, OUMS37 cells were harvested and
resuspended in lysis buffer (50mM Tris-HCl (pH 8.0), 10mM
EDTA, 0.3% Triton X-100) for 30min on ice. After centrifugation
at 15000rpm for 5min, the supernatant was treated with RNase
(100mgml
 1) for 30min at 551C and then with proteinase K
(400mgml
 1) for another 1h at 551C. The cell lysates were
extracted with phenol–chloroform. DNA was precipitated with
ethanol, and electrophoresed on 2% agarose gels.
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Bisulphite treatment of genomic DNA was carried out using
Methylampt One-Step DNA Modificaion Kit (Epigentek Group
Inc., Brooklyn, NY, USA), according to the manufacturer’s
instructions. Methylation-specific PCR (MSP) and bisulphite-
sequencing analyses were performed as described previously
(Wen et al, 2006). Primer sequences used for all analyses are
available upon request.
Statistical analysis
w
2-test was used to compare the values for the test and control
samples, and a value of Po0.05 was taken as significant. Patient
survival was calculated from the date of surgery until death or the
date of last follow-up. Survival was evaluated by the Kaplan–Meier
method, and the differences were evaluated with the log-rank test.
RESULTS
Frequent downregulation of SOX2 mRNA in gastric cancer
cell lines and primary gastric carcinoma tissues
To determine SOX2 expression levels, we performed RT–PCR
analysis in 10 human gastric cancer cell lines and the normal
stomach mucosae. Among the 10 cell lines we investigated,
7 showed low or undetectable levels of SOX2 mRNA compared
with the normal stomach mucosae (Figure 1A). To assess SOX2
expression levels in primary gastric cancer samples, we examined
the expression levels of SOX2 mRNA using quantitative real-time
RT–PCR in primary gastric carcinoma tissues and corresponding
noncancerous mucosae. Significant reductions of SOX2 expres-
sions were observed in 6 out of 13 cases (cases 1, 3, 6, 8, 9 and 13)
(Figure 1B). Representative results of the endpoint RT–PCR are
shown in Figure 1C.
Exogenous SOX2 inhibits proliferation of gastric epithelial
cell lines
To perform functional analysis of SOX2, we transiently expressed
exogenous SOX2 in two human gastric cancer cell lines (NUGC3 and
GCIY) and OUMS37 cells derived from rat gastric epithelia by using
an adenovirus system. According to GFP expression, over 70% of
the cells were infected with the vectors (Figure 2A). Although these
cell lines showed basally low levels of SOX2 expression, abundant
SOX2 protein was detected after Ad-SOX2 infection but not after the
control Ad-GFP infection (Figure 2B). We found that SOX2-
overexpressing cells exhibited dramatic morphological changes,
that is, a round shape and floating, but such changes were not found
in the control Ad-GFP-infected cells (Figure 2A).
To determine the proliferation rates after overexpression of
SOX2 in gastric cell lines, growth curves were generated for each
cell line by means of WST-1 assay over a 5-day period. We found
that all SOX2-overexpressing cell lines showed significant growth
inhibition compared with the control Ad-GFP-infected cells
(Figure 2C).
SOX2 induces cell-cycle arrest in gastric cell lines
To clarify the mechanisms underlying growth inhibition by SOX2
in gastric cell lines, we performed cell-cycle analysis by flow
cytometry on cells stained with propidium iodide. We chose
OUMS37 cells, for which the growth inhibition by SOX2 over-
expression was the highest among the three cell lines (Figure 2C).
At 24h after infection, the Ad-SOX2-infected OUMS37 cells
showed a higher proportion of cells in G1 phase (58.4%), compared
with the control cells (41.6% for parental cells and Ad-GFP-
infected cells), and concomitant decreases in the proportions of
cells in S and G2/M phases (Figure 3A).
To investigate potential molecular mechanisms for SOX2-
induced G1 arrest in gastric epithelial cells, we next explored the
effects of SOX2 on expression of cell-cycle-regulatory proteins.
Western blot analysis showed that the protein levels of cyclin D1
and phosphorylated Rb were decreased, whereas that of p27
Kip1
was increased in the Ad-SOX2-infected OUMS37 cells, compared
with control cells (Figure 3B). These changes in cell-cycle-
regulatory proteins were also seen in human gastric cancer cell
lines NUGC3 and GCIY on SOX2 overexpression (Figure 3B).
Unexpectedly, the protein level of p21
Cip1 was significantly
decreased in the Ad-SOX2-infected OUMS37 cells compared with
the control cells, whereas p21
Cip1 proteins were undetectable levels
in the NUGC3 and GCIY cell lines (Figure 3B).
We further performed the knockdown of endogenous SOX2 by
siRNA in the SOX2-positive human gastric cancer cell lines. After
transfection of SOX2 siRNA in MKN45 and TGBC11TKB cells,
expression of endogenous SOX2 protein was reduced in both cell
lines compared with control nonspecific siRNA-transfected cells
(Figure 3C). Consequently, phosphorylated Rb level was signifi-
cantly increased, whereas p27
Kip1 was decreased in both cell lines
compared with control cells (Figure 3C).
SOX2 induces apoptosis in gastric cells through a
caspase-3-dependent pathway
As shown in Figure 2A, dramatic morphological changes that
seemed to be hallmarks associated with apoptosis were observed in
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Figure 1 SOX2 mRNA expression in gastric cancer cell lines and primary
gastric carcinoma tissues. (A) RT–PCR analysis of SOX2 mRNA levels in 10
gastric cancer cell lines and the normal stomach mucosae (normal st.).
GAPDH expression was used as an internal loading control. RT (þ or  )
indicates reverse transcriptase added or not, and H2O indicates no RNA
added. (B) Quantitative real-time RT–PCR analysis of SOX2 mRNA levels
in primary gastric carcinoma samples and corresponding noncancerous
gastric mucosae from the same patients. SOX2 expression levels were
normalised by internal GAPDH expression. The assay was performed in
triplicate, and the bars indicate s.d. (C) Representative results of the
endpoint RT–PCR of SOX2 in primary gastric carcinomas (lanes Ca) and
noncancerous gastric mucosae (lanes N).
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apoptosis occurred in SOX2-overexpressing cells, we performed
flow cytometry analysis. As shown in Figure 4A, a significant
increase in the percentage of cells with a hypodiploid (sub-G1)
DNA content was observed in SOX2-overexpressing OUMS37 cells
(20.6 and 35.8% for 48 and 72h, respectively) in comparison with
the control Ad-GFP-infected cells (5.5 and 6.7% for 48 and 72h,
respectively).
To further characterise the apoptosis, we performed
APOPercentage Apoptosis assay in the Ad-SOX2-infected OUMS37
cells. The APOPercentage Apoptosis assay is a detection and
measurement system for monitoring the occurrence of apoptosis,
involving APOPercentage Dye that is selectively imported by cells
undergoing apoptosis with modified cell membrane phospholipid
composition, showing purple-red staining due to the accumulation
of the APOPercentage Dye. As shown in upper panels of Figure 4B,
there were many purple-red-stained apoptotic cells in the Ad-
SOX2-infected OUMS37 cells, but not in the control Ad-GFP-
infected cells. The percentage of apoptotic cells per total cells was
determined, and a significant increase in apoptotic cells was
observed in Ad-SOX2-infected OUMS37 cells (2.5 and 12.9% for 48
and 72h, respectively) compared with the control Ad-GFP-infected
cells (0.7 and 0.9% for 48 and 72h, respectively; Figure 4B,
bottom). We further performed the DNA ladder assay, and
observed a typical DNA ladder formation in the Ad-SOX2-infected
OUMS37 cells, but not in the control Ad-GFP-infected and parental
OUMS37 cells (Figure 4C).
To confirm whether these cell deaths were caspase dependent
or independent, we examined the effects of SOX2 on the activation
of caspase-3, an effector caspase. Western blot analysis showed
that the protein level of the inactivated form of caspase-3 (35kDa)
was decreased, while the activated form of caspase-3 (17kDa)
appeared, and the caspase substrate PARP was diminished in the
Ad-SOX2-infected OUMS37 cells at 48 and 72h after infection
compared with the control Ad-GFP-infected and parental cells
(Figure 4D).
Epigenetic silencing of the SOX2 gene in gastric cancer cell
lines
Next, we tried to clarify the mechanisms underlying the loss of
SOX2 expression in gastric cancers. As there is a dense CpG island
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Figure 2 Effects of SOX2 overexpression on the proliferation of gastric epithelial cell lines. (A) Morphological changes in OUMS37, NUGC3 and GCIY
cell lines after infection with the Ad-SOX2 or Ad-GFP. The MOI of the adenovirus vectors were 80 for OUMS37 and 20 for NUGC3 and GCIY,
respectively. The left and right panels show the phase contrast micrographs appearance and fluorescent micrographs for GFP expression in the same fields.
(B) Western blot analysis of SOX2 protein expression after adenovirus-mediated overexpression in OUMS37, NUGC3 and GCIY cell lines. SOX2 protein
expression levels were compared among parental cells (P), Ad-GFP-infected cells (MOI: G80 for OUMS37, and G20 for NUGC3 and GCIY, respectively)
and Ad-SOX2-infected cells (MOI: S40 and S80 for OUMS37, and S10 and S20 for NUGC3 and GCIY, respectively) at 48h after adenovirus infection.
a-tubulin expression was used as a protein loading control. (C) In vitro cell proliferation assay after SOX2 overexpression in gastric cell lines. The number of
viable cells was measured by WST-1 assay of 1, 3 and 5 days after adenovirus infection. The assay was performed in triplicate, and bars indicate s.d.
Roles of SOX2 in gastric carcinogenesis
T Otsubo et al
827
British Journal of Cancer (2008) 98(4), 824–831 & 2008 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sin the 50 and exon regions of SOX2 (Figure 5A), we analysed DNA
methylation status of SOX2 in human gastric cancer cell lines. To
initially study the epigenetic status of SOX2 in gastric cancer cell
lines, we used a demethylating agent, 5-aza-20-deoxycytidine.
RT–PCR analysis revealed that the basally silent SOX2 gene was
re-expressed in MKN74 and HSC59 cell lines after 5-aza-
20-deoxycytidine treatment, whereas all the other cell lines, such
as MKN7, did not restore the expression of SOX2 with this drug
treatment (Figure 5B). Furthermore, in MKN74 and HSC59 cell
lines, restoration of SOX2 by 5-aza-20-deoxycytidine reinduced
expression of p27
Kip1 that was upregulated in the Ad-SOX2
infected cells, although the level of induction was weak in HSC59
cells (Figure 5B). On the other hand, the treatment with a histone
deacetylase inhibitor, trichostatin A (TSA), could not restore SOX2
expression in these cell lines except MKN7 with a weak restoration
(data not shown).
As shown in Figure 5A, we designed two MSP primer sets (MSP-
A and MSP-B). Among the 10 gastric cancer cell lines, MKN74 and
HSC59 exhibited the hypermethylation signals only with the MSP-
B primer set (Figure 5C). In contrast, normal stomach mucosae
exhibited an unmethylated status using both primer sets
(Figure 5C). Bisulphite sequencing data of MKN74, HSC59 and
KATO-III are consistent with the ones of MSP analyses
(Figure 5D), indicating that the methylation status using the
MSP-B primers is strongly related to SOX2 expression patterns.
SOX2 methylation status in primary gastric carcinoma
tissues
To investigate the relationship between SOX2 expression levels and
methylation status in primary gastric carcinoma tissues, we
initially examined SOX2 methylation status in 13 primary gastric
cancer tissues and corresponding noncancerous mucosae (cases
1–13) prepared from frozen samples, whose expression levels of
SOX2 were already examined (Figure 1B). Among the 13 cases, the
hypermethylation signals of SOX2 were observed in 3 cases (cases
3, 8 and 13), in which SOX2 expression was downregulated,
whereas all the other cases, such as case 12, revealed the
unmethylated status by the MSP analysis (Figure 6A). Although
a noncancerous sample (Figure 6A, case 8N) displayed a weak
methylation signal at 35 cycles of PCR condition, the methylation
band disappeared in PCR cycles at 32 (data not shown) and
bisulphite sequencing did not show any clone with dense
methylation signals (Figure 6B, case 8N). Thus, we regarded this
weak band in case 8N as negative, and all the 13 noncancerous
tissues expressing SOX2 were found to be methylation negative. On
the other hand, densely methylated clones were observed in the
SOX2 downregulated primary gastric carcinoma tissue (Figure 6B,
case 8Ca). These data strongly suggest the correlation between the
SOX2 hypermethylation and its reduced expression in primary
gastric carcinoma tissues.
We subsequently investigated the methylation status of the
additional cases (61 and 11 for gastric carcinomas and corre-
sponding noncancerous gastric mucosae, respectively) from
paraffin-embedded samples by the MSP analysis. The representa-
tive results of SOX2-methylation-positive (cases 16, 18, 21 and 30)
and -negative (cases 39 and 47) cases are shown in Figure 6A.
Altogether, 12 out of 74 (16.2%) primary gastric carcinoma tissues
exhibited the hypermethylation signals of SOX2, whereas none of
the 24 corresponding noncancerous tissues did (Fisher’s exact
probability test, P¼0.027).
When we analysed a relationship between the SOX2 methylation
status and clinicopathological features of the gastric cancer cases,
there was no significant correlation between the SOX2 methylation
status and sex, age, depth of tumour invasion and histological type
(data not shown). However, among the 52 patients with advanced
gastric cancers, Kaplan–Meier analysis demonstrated that those
with cancers showing SOX2 methylation had a significantly shorter
survival than those without this methylation (P¼0.0062; Figure 6C).
DISCUSSION
We have previously reported that the SOX2 protein level was often
reduced in human gastric carcinoma tissues on immunohisto-
chemical analysis (Li et al, 2004). In the present study, we found
that expression levels of SOX2 mRNA were frequently down-
regulated in human gastric cancer cell lines and primary gastric
carcinomas. These results are consistent with our previous studies,
and indicate that downregulation of the SOX2 protein may occur at
a transcriptional level in gastric cancer cells.
In the present study, we performed functional characterisation
of SOX2 in gastric epithelial cell lines by adenoviral overexpression
of SOX2, and we found that exogenous SOX2 inhibited cell
proliferation through cell-cycle (G1) arrest and apoptosis.
Generally, overgrowth due to the deviation from canonical cell
cycle and/or loss of the propensity to undergo apoptosis are
critical events in the development of cancer (Lowe and Lin, 2000;
Sherr, 2000). Hence, our present data suggest that SOX2 plays a
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Figure 3 Effects of SOX2 on cell cycle. (A) Cell-cycle analysis of
parental, Ad-GFP- and Ad-SOX2-infected OUMS37 cells at 24h after
infection. DNA content was measured by propidium iodide staining on
flow cytometry. The percentages of cell-cycle phases are shown in each
panel. (B) Differential expression of the cell-cycle-regulatory proteins
associated with SOX2 overexpression. Western blot analysis was
performed to compare expression levels of cyclin D1, pRb, p27
Kip1 and
p21
Cip1 proteins among parental, Ad-GFP- and Ad-SOX2-infected cells.
Expression of a-tubulin was used as a protein loading control. (C) Western
blot analysis of cell-cycle-regulatory proteins expression after transfection
with SOX2 siRNA (S) or control siRNA (C) in MKN45 and TGBC11TKB
cell lines. Ad-SOX2-infected NUGC3 cells (Ad-SOX2) were used as a
positive control of the SOX2 protein band. Expression of a-tubulin was
used as a protein loading control.
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loss of SOX2 expression may cause gastric epithelial cells develop
into carcinomas.
We demonstrated that decreased protein levels of cyclin D1 and
phosphorylated Rb, and increased protein levels of p27
Kip1 were
associated with SOX2 overexpression. Moreover, knockdown of
SOX2 by siRNA upregulated phosphorylated Rb and down-
regulated p27
Kip1 in the two gastric cancer cell lines. These results
are consistent with the increased proportion of G1 phase shown in
the Ad-SOX2-infected OUMS37 cells. Downregulation of the cyclin
D1 mRNA and upregulation of the p27
Kip1 mRNA were also
observed after SOX2 overexpression (data not shown), indicating
that these cell-cycle-regulating factors may be controlled by SOX2
at the transcriptional levels. It has been reported that b-catenin
activates the transcription of cyclin D1 through TCF-binding sites
within the promoter, resulting in a direct effect on cell prolifera-
tion in colon carcinoma cells (Tetsu and McCormick, 1999),
whereas SOX2 associates with b-catenin in osteoblasts and inhibits
the activity of a Wnt-responsive reporter plasmid in HEK293 cells
(Mansukhani et al., 2005). It is, thus, possible that SOX2 may
function in the cell cycle through interaction with Wnt signals in
gastric epithelial cells. On the other hand, our present data strongly
suggest the association between SOX2 and p27
Kip1 by means of
overexpression and knockdown experiments. Recently, it has been
reported that knockdown of SOX9, another SOX family member,
induced cell-cycle arrest at G1 and upregulated p27
Kip1 in prostate
cancer cells (Wang et al., 2007), indicating that SOX9 positively
regulates cell-cycle progression though inhibiting p27
Kip1. How-
ever, it is controversial because other groups reported SOX9 as a
suppressor of cell-cycle progression (Panda et al., 2001; Afonja
et al, 2002; Drivdahl et al, 2004). Thus, further studies are
necessary to clarify the role of SOX2 in the regulation of cell cycle.
We further elucidated that exogenous expression of SOX2
induced typical apoptosis, which accompanied by the caspase-3
activation, in gastric epithelial cells. Among the wide spectrum of
apoptosis-regulatory genes, such as Bax, Bcl-2, Puma, FasL, and so
on, no remarkable changes in expression of any genes were
observed in Ad-SOX2-infected OUMS37 cells (data not shown). It
has been reported that other SOX family members, such as SOX4
and SOX9, induce apoptosis in bladder, prostate and colon
carcinomas (Drivdahl et al, 2004; Jay et al, 2005; Aaboe et al,
2006), being consistent with our finding. However, transcriptional
targets of SOX family members involving apoptosis have been
poorly understood yet. In the present study, p21
Cip1 was found to
be downregulated in SOX2-overexpressing OUMS37 cells, whose
expression change has also been detected in mRNA levels (data
not shown). This observation is surprising, because p21
Cip1 is an
inhibitor of cell-cycle progression and is known as a tumour
suppressor (Harper et al, 1993). However, recent finding has
shown that p21
Cip1 is implicated in the antiapoptotic response to
chemotherapy (Gartel and Tyner, 2002). As a negative regulator of
apoptosis, p21
Cip1 interacts with several caspases, such as caspase-
3, caspase-8 and caspase-10 (Gartel and Tyner, 2002). Moreover,
it was reported that upregulation of p21
Cip1 confers resistance to
apoptosis in human gastric cancer cell lines MKN28 and MKN45
(Liu et al, 2004). Meanwhile, it has been reported that p27
Kip1
positively regulates, at least in part, the apoptotic response of
gastric epithelial cells to H. pylori (Eguchi et al, 2004). As these
reports are consistent with our present data, SOX2 may induce
apoptosis through p21
Cip1 and/or p27
Kip1 in gastric epithelial cells.
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Figure 4 Analyses of apoptosis associated with SOX2 overexpression in OUMS37 cells. (A) Percentage of the sub-G1 DNA fraction in OUMS37 cells at
48 and 72h after infection. DNA was stained with propidium iodide and the sub-G1 fraction was measured by flow cytometry. The percentages of the sub-
G1 fractions, indicated by the bars, are shown in each panel. (B) Apoptosis detection by APOPercentage Apoptosis assay. Top panels: phase contrast
micrographs indicate representative areas of the control (Ad-GFP 40MOI) and SOX2-overexpressing (Ad-SOX2 40MOI) OUMS37 cells at 72h after
adenovirus infection. Bottom panel: purple-red-stained apoptotic cells were counted in multiple randomly selected fields and the percentage (per total cells)
was determined (columns, mean of 10 fields; bars, s.d.). (C) DNA ladder assay by agarose gel electrophoresis. DNA extracted from the control (parental
and Ad-GFP 40MOI for 72h) and SOX2-overexpressing (Ad-SOX2 40MOI for 48 and 72h) OUMS37 cells was electrophoresed on a 2% agarose gel and
detected by ethidium bromide staining. Arrows indicate the molecular weights of DNA base pairs. (D) Detection of activated caspase-3 in SOX2-
overexpressing OUMS37 cells on western blot analysis. The reduction of caspase-3 and accompanying appearance of cleaved-caspase-3 indicate activation
of caspase-3. The reduction of a caspase-3 substrate, PARP, also reflects activation of caspase-3. Expression of a-tubulin was used as a protein loading
control.
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induced cell-cycle arrest at an early time point and apoptosis at a
later time point in gastric epithelial cells. In the normal stomach,
terminally differentiated epithelial cells stop proliferation and
eventually culminate in apoptosis (Johnson, 1988). Our present
results may therefore be similar to the normal cell differentiation
process in the stomach. Furthermore, SOX2 has been found to
upregulate the expression levels of gastric differentiation markers,
MUC5AC and pepsinogen A (Li et al, 2004; Tani et al, 2007). These
data, combined with the findings for antiproliferation effects of
SOX2 in gastric epithelial cell lines, suggest that SOX2 may control
the gastric epithelial cells differentiating into mature cells and its
disruption may cause continual dividing, eventually leading to
gastric cancer. However, further investigations, for example,
generation of an animal model, are necessary to understand the
precise SOX2 functions in the normal stomach differentiation.
Finally, we investigated the methylation status of SOX2 in
human gastric cancer cell lines and primary gastric carcinoma
tissues. Two SOX2 expression-negative gastric cancer cell lines
(MKN74 and HSC59) exhibited the hypermethylation signals by
MSP and bisulphite sequencing, and restored the SOX2 expression
after the demethylating agent treatment. Furthermore, the SOX2
hypermethylation was more frequently observed in primary gastric
carcinomas than corresponding noncancerous mucosae (16.2 vs
0%, respectively). Particularly in SOX2-downregulated cases, half
of the cases (three out of six) showed the hypermethylation signals.
These data strongly suggest that aberrant DNA methylation is one
of the key mechanisms underlying SOX2 downregulation in gastric
cancers. Nevertheless, it is important to search for other
mechanisms, such as histone modification, in gastric cancers,
because several SOX2 expression-negative cases did not show any
DNA methylation. In fact, a gastric cancer cell line MKN7 weakly
restored its expression after treatment with a histone deacetylase
inhibitor TSA.
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Figure 5 Methylation status of SOX2 in gastric cancer cell lines. (A)
Schematic representation of the human SOX2 gene. Open and closed
boxes indicate the untranslating and coding regions, respectively, and an
arrow denotes the transcription start site (þ1). Vertical bars show CpG
sites. Arrows below the CpG sites indicate the regions subjected to MSP
(MSP-A and MSP-B) and bisulphite sequencing (BS-A and BS-B). (B)
Representative results of the demethylation analysis of SOX2. Gastric
cancer cell lines were treated with (lanes A) or without (lanes M; mock) 5-
aza-20-deoxycytidine (5mM), and SOX2 expression was examined by RT–
PCR as described in Figure 1A. p27
Kip1 expression was also examined. (C)
MSP analyses in gastric cancer cell lines and the normal stomach. The
primer region is depicted in panel A. Bands in the ‘Mt’ lanes, as shown by
arrowheads, are PCR products obtained with methylation-specific primers;
those in the ‘U’ lanes are obtained with unmethylated-specific primers. (D)
Sodium bisulphite DNA sequencing of SOX2 in gastric cancer cell lines
(KATOIII, MKN74 and HSC59). The analysed regions are shown in panel A.
Each horizontal row of circles represents analysis, in single clone of
bisulphite-treated DNA, of 22 or 41 CpG sites (for BS-A or BS-B,
respectively) contained in the regions. Solid and open circles represent
methylated and unmethylated CpG sites, respectively.
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Figure 6 Methylation status of SOX2 in primary gastric carcinoma
tissues, and its involvement in prognosis. (A) Representative results of MSP
analysis of SOX2 in primary gastric carcinomas (lanes Ca) and corresponding
noncancerous gastric mucosae (lanes N). All analyses were carried out
by using MSP-B primers (shown in Figure 5A). (B) Sodium bisulphite DNA
sequencing of SOX2 in noncancerous gastric mucosae (Case 8N) and
primary gastric carcinoma (Case 8Ca) tissue samples. The analysed regions
(BS-B) are shown in Figure 5A. Each horizontal row of circles represents
analysis, in single clone of bisulphite-treated DNA, of 41 CpG sites
contained in the regions. Solid and open circles represent methylated and
unmethylated CpG sites, respectively. (C) Kaplan–Meier survival analysis of
SOX2 methylation in 52 advanced gastric cancer patients. Patients with
SOX2 methylation (Mt; dotted) had a significantly poorer outcome than
those without methylation (U; solid) (P¼0.0062).
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showing SOX2 methylation had a significantly shorter survival
time than those without its methylation. It has been reported that
low expression levels of p27
Kip1 protein are related with a poor
outcome in many human gastric cancers (Mori et al, 1997). In
addition, the expression of the cyclin D1 and p27
Kip1 proteins is
inversely correlated and is associated with a poor clinical outcome
in human gastric cancer (Han et al, 1999). These findings,
combined with our present data, suggest that downregulation of
SOX2 through aberrant DNA methylation and resultant alteration
of cyclin D1 and p27
Kip1 protein levels may be associated with poor
prognoses in gastric cancers, and that SOX2 methylation can be a
clinically useful prognostic marker for advanced gastric cancer
patients.
In conclusion, we revealed that SOX2 expression was frequently
downregulated in gastric cancers, some of which were due to
aberrant DNA methylation. Moreover, we also showed that
exogenous SOX2 expression inhibited cell growth through cell-
cycle arrest and apoptosis in gastric cells. We have demonstrated,
for the first time, SOX2 as a tumour-suppressive gene in gastric
cancers, and our findings may lead to new therapeutic approaches
for gastric cancer.
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